close
close

Every Cure announces the addition of drug development leaders to its leadership team

Richard Riese, MD, PhD, and Ruxandra Draghia-Akli, MD, PhD, join Every Cure as chief medical officer and chair of the scientific advisory board, respectively.

PHILADELPHIA, Oct. 1, 2024 /PRNewswire/ — Every Cure, a nonprofit biotech company that uses AI to unlock the potential of every approved drug to treat every possible disease, is pleased to announce the addition of two new pharmaceutical executives give development industry to its medical research team. Every Cure is committed to evaluating and advancing the most promising therapeutic opportunities for all medicines and diseases and collaborates with world-class experts in clinical research studies. By incorporating deep expertise in translational research into the team, Every Cure ensures that AI-driven treatment predictions are validated and effectively reach patients in need. As the strength of Every Cure's AI platform continues to grow, the organization remains dedicated to validating treatment predictions through laboratory work and clinical trials, translating data into tangible cures. These strategic appointments reflect Every Cure's commitment to innovation and excellence in discovering new uses for existing medicines and driving significant breakthroughs in patient care and health outcomes worldwide.

“I am pleased to welcome our exceptional new leadership team members,” said Grant Mitchell, MD, MBA, co-founder and chief executive officer of Every Cure. “Their combined capabilities in clinical development, drug discovery and organizational strategy are key to advancing our mission to bring life-saving therapies to those who need them most.”

The new team members will drive the initiative to translate predictions from Every Cure's AI model into a pipeline of clinically validated treatments for neglected diseases. Predicted drug-disease matches undergo rigorous assessment for mechanistic rationale and clinical relevance to facilitate their dissemination to patients and refine the AI ​​platform to accelerate access to life-saving treatments.

Introducing the new members of the management team:

  • Richard Riese, MD, PhD Dr. Riese serves as Chief Medical Officer at Every Cure. He is a physician-scientist with over 20 years of experience in the biopharmaceutical industry and academic medicine, driven by a deep commitment to providing treatments for patients suffering from rare and debilitating diseases. Dr. Riese brings extensive clinical development experience at large and small biopharmaceutical companies, including Pfizer, Alexion and Alnylam. Most recently, he was senior vice president and head of clinical research at Allovir, Inc., where he oversaw the clinical development of virus-specific T cells to combat latent viral infections in immunocompromised individuals. His expertise will be invaluable in leading Every Cure's efforts to identify and advance the development of effective, repurposed therapies and ensure innovative treatments reach patients more quickly and safely.
  • Ruxandra Draghia-Akli, MD, PhD-Dr. Draghia-Akli serves as chair of Every Cure's Scientific Advisory Board. Her extensive career in human genetics, rare diseases, gene therapies, and nucleic acid vaccines has made significant contributions to public health. At Johnson & Johnson, she led the creation of a global public health research and development organization focused on developing solutions for critical health threats such as dengue fever and tuberculosis. She played a key role in the European Commission's health initiatives and co-chaired the ACTIV program initiated by the US National Institutes of Health. Dr. Draghia-Akli will join Novavax in November 2024 as executive vice president and head of research and development (R&D), focusing on building partnerships with industry and public health organizations. As Chair of the Scientific Advisory Board for Every Cure, Dr. Draghia-Akli will use her extensive experience and strategic vision to lead Every Cure's efforts in identifying and promoting drug repurposing opportunities with the greatest potential impact.

This expanded leadership team represents a strategic improvement to Every Cure's leadership and underscores the organization's commitment to advancing its mission with renewed vigor and expertise. These colleagues' diverse backgrounds in drug development, global health and operational strategy combine to strengthen the organization's performance. Under her leadership, Every Cure aims to transform the global treatment landscape, improving health outcomes and improving the quality of life for countless people.

For more information about Every Cure's initiatives and how you can contribute, visit EveryCure.org.

For more information or to express interest in partnering with Every Cure, please contact us at [email protected]

About every healing

Any healing is a non-profit biotechnology company that uses AI to unlock the potential of every approved drug to treat all kinds of diseases. Every Cure believes that drug reuse is the fastest, most efficient way to address critical health challenges while optimizing return on investment to save lives. Unfortunately, systemic barriers often hinder effective repurposing, leaving patients unable to access available potential treatments. To address these challenges, Every Cure leverages its AI platform to efficiently identify and evaluate drug repurposing opportunities for all medicines and diseases. This process is based on objective data and insights from global experts, patient advocacy groups and research foundations, ensuring a comprehensive strategy that maximizes the potential for discovering effective, repurposed treatments. Every Cure's goal is to update clinical guidelines and, as part of its mission, potentially conduct clinical trials to ensure effective therapies reach those in need. Every Cure proudly announced its launch in September 2022 Clinton Global Initiative.

For more information, please visit EveryCure.org or contact us at Twitter, LinkedIn, FacebookAnd Instagram.

Decision View original content to download multimedia:

SOURCE Every Cure